Design Therapeutics

Design Therapeutics

Biotechnology Research Carlsbad, Ca, United States 66 employees
Employees
66
Contacts
2
Emails
2
Phones
2

Design Therapeutics Overview

Headquarters
Carlsbad, Ca, United States
Website
designtx.com
Industry
Biotechnology Research
Employees
66
Founded
2017
Funding
125.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Design Therapeutics

We are a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC™ gene targeted chimera small molecules. The company’s GeneTAC™ molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. Design’s lead program is focused on the treatment of Friedreich ataxia, followed by programs in Fuchs endothelial corneal dystrophy and myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions. For more information, please visit designtx.com.

Design Therapeutics Contact Details

People in AeroLeads
4
With contact data
2
Email contacts
2
50.0% coverage
Phone contacts
2
50.0% coverage

Design Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Laura Weston Vice President, Product Development
View
John Schmid
Email Phone
Mustapha Parekh
Email Phone
Frederic Roy Carlson, Jr.
View

Employees by Management Level

Individual contributor 5 profiles
Senior / Lead 3 profiles
Director 2 profiles
Executive 1 profile
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 6 6 0
Finance 1 1 1
Operations 1 1 0

Design Therapeutics Tech Stack

Data / AI 4 profiles
Product / design 4 profiles

Compare Similar Companies to Design Therapeutics